Drawing for PROSHAPE

USPTO serial 79338447

PROSHAPE

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
SWAIN, MICHELE LYNN
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROSHAPE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Food supplements in tablet, capsule, powder, paste, granule, bar or gel form; medicinal herbsSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 3, 2023DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jul 2, 2023DETHDEATH OF INTERNATIONAL REGISTRATION
Jan 23, 2023RFNTREFUSAL PROCESSED BY IB
Jan 3, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 3, 2023RFRRREFUSAL PROCESSED BY MPU
Oct 15, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2022DOCKASSIGNED TO EXAMINER
May 6, 2022MAFRAPPLICATION FILING RECEIPT MAILED
May 2, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 14, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance